financetom
Business
financetom
/
Business
/
AbbVie to Acquire Capstan Therapeutics for up to $2.1 Billion
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
AbbVie to Acquire Capstan Therapeutics for up to $2.1 Billion
Jun 30, 2025 5:58 AM

08:43 AM EDT, 06/30/2025 (MT Newswires) -- AbbVie ( ABBV ) said Monday that it has agreed to acquire clinical-stage biotechnology company Capstan Therapeutics.

AbbVie ( ABBV ) said it will pay up to $2.1 billion in cash at closing.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved